Provided by Tiger Trade Technology Pte. Ltd.

Bio-Techne

72.32
+0.04000.06%
Post-market: 72.320.00000.00%19:30 EDT
Volume:3.96M
Turnover:286.20M
Market Cap:11.27B
PE:62.34
High:72.35
Open:72.32
Low:72.27
Close:72.28
52wk High:72.62
52wk Low:43.20
Shares:155.81M
Float Shares:155.81M
Volume Ratio:1.46
T/O Rate:2.54%
Dividend:0.32
Dividend Rate:0.44%
EPS(TTM):1.16
EPS(LYR):1.16
ROE:9.03%
ROA:6.26%
PB:5.34
PE(LYR):62.34

Loading ...

Merck KGaA downgraded to Hold from Buy at HSBCBio-Techne

TIPRANKS
·
Jul 06

Piper Sandler Adjusts Bio-Techne Price Target to $73 From $60, Maintains Neutral Rating

MT Newswires Live
·
Jul 01

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bio-Techne (TECH), Concentra Group Holdings Parent, Inc. (CON) and Palvella Therapeutics (PVLA)

TIPRANKS
·
Jul 01

Merck Kgaa Agrees to Buy Bio-techne for USD 73 a Share in Cash

Reuters
·
Jul 01

Bio-techne Cut to Hold from Buy by Benchmark

Dow Jones
·
Jun 30

Benchmark Downgrades Bio-Techne to Hold From Buy

MT Newswires Live
·
Jun 30

Bio-techne Corp : Benchmark Cuts to Hold from Buy

THOMSON REUTERS
·
Jun 30

U.S. Research Roundup- Comcast, Honeywell Aerospace, Qualys

Reuters
·
Jun 30

Bio-Techne downgraded to Hold from Buy at TD Cowen

TIPRANKS
·
Jun 30

Bio-techne Cut to Neutral from Buy by Citigroup

Dow Jones
·
Jun 29

Citigroup Downgrades Bio-Techne to Neutral From Buy, Adjusts PT to $73 From $70

MT Newswires Live
·
Jun 29

Buzz-us Stocks Weekly: AI Reality

Reuters
·
Jun 29

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Monopar Therapeutics Inc (MNPR) and Bio-Techne (TECH)

TIPRANKS
·
Jun 29

U.S. Research Roundup-3m Co, Nike, Primoris Services

Reuters
·
Jun 29

Weekly Winners | Bio-Techne Soars 23%; AbbVie Surges 17%; United Airlines Jumps 15%; Corning, Merck Gain 13%

Tiger Newspress
·
Jun 28

Bio-Techne downgraded to Neutral from Buy at Citi

TIPRANKS
·
Jun 27

US Stocks Weekly: AI Reality

Reuters
·
Jun 27

Health Care Roundup: Market Talk

Dow Jones
·
Jun 27

Stephens Downgrades Bio-Techne to Equal Weight From Overweight, Adjusts Price Target to $73 From $68

MT Newswires Live
·
Jun 26

Bio-techne is Maintained at Neutral by Baird

Dow Jones
·
Jun 26